Acquisition by Silverman Joshua of 200000 shares of MyMD Pharmaceuticals at 1.66 subject to Rule 16b-3
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
Filed transaction by MyMD Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
MYMD Old is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| UBX | Unity Biotechnology | 34.59 | ||||
| NBY | NovaBay Pharmaceuticals | 9.37 | ||||
| PASG | Passage Bio | 1.52 | ||||
| GOVX | GeoVax Labs | 1.36 | ||||
| KZR | Kezar Life | 1.06 | ||||
| AVIR | Atea Pharmaceuticals | 2.10 | ||||
| KROS | Keros Therapeutics | 2.22 | ||||
| KRON | Kronos Bio | 3.03 | ||||
| LRMR | Larimar Therapeutics | 3.43 | ||||
| LGND | Ligand Pharmaceuticals | 3.89 | ||||
| REPL | Replimune | 4.08 | ||||
| RXRX | Recursion Pharmaceuticals | 5.23 | ||||
| BOLT | Bolt Biotherapeutics | 5.26 | ||||
| XBIO | Xenetic Biosciences | 5.39 | ||||
| NVCT | Nuvectis Pharma | 5.83 | ||||
| ORIC | Oric Pharmaceuticals | 6.35 | ||||
| GOSS | Gossamer Bio | 7.62 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| LYRA | Lyra Therapeutics | 9.09 | ||||
| DSGN | Design Therapeutics | 11.02 | ||||
| SRZN | Surrozen | 12.96 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |